Chronic myeloid leukaemia (CML)

Slides:



Advertisements
Similar presentations
TA OGUNLESI (FWACP)1 CHILDHOOD LEUKAEMIA. TA OGUNLESI (FWACP)2 LEUKAEMIA Heterogenous group of malignant disorders Characterised by uncontrolled clonal.
Advertisements

HAEMATOLOGY MODULE: LEUKAEMIA (LECTURE 1) CHEMOTHERAPY Adult Medical-Surgical Nursing.
Introduction To Haematological Malignancies
LEUKEMIA.
Armaan Khalid. What is Leukaemia?  Cancer of the blood or bone marrow  Can be classified: Acute/chronic Myeloid/lymphoid.
Chronic leukaemias Chronic myelogenous leukaemia Chronic myelogenous leukaemia Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia.
Common Haematological Malignancies
Acute Leukaemia Dr. Soheir Adam, MRCPath Assistant Professor Department of Haematology, KAUH.
1 Chronic Leukemia Dr.Huad alkarim.. 2 What Are the Types of Chronic Leukemia?
CHRONIC MYELOID LEUKAEMIA.. CLINICAL FEATURES. Rare below the age of 20 years, but occurs in all decades, with a median age of onset of years. Rare.
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
WHO CLASSIFICATION OF MYELOID NEOPLASMS 2000  Chronic myeloproliferative disorders (CMPD)  Myelodysplastic / myeloproliferative diseases (MDS/MPD) 
Chronic lymphocytic leukemia (1)
Chronic Lymphocytic Leukemia (CLL) DEFINITION CLL is a neoplastic disease characterized by proliferation and accumulation (blood, marrow and lymphoid.
Chapter 17 Chronic Leukemias.
Chronic Lymphocytic Leukemia. Definition Clonal B cell malignancy. Progressive accumulation of long lived mature lymphocytes. Increase in anti-apoptotic.
Chronic Leukemia Dr. Rania Alhady Chronic Lymphocytic leukemia (CLL):
Chronic leukemias. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
Chronic Myeloid Leukemia Leukemia ALL, AML, CLL ALL, AML, CLL Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia –Cancer of the granulocytes or.
CHRONIC MYELOID LEUKAEMIA Dr Rosline Hassan Department of Haematology School of Medical Sciences Universiti Sains Malaysia.
The acute Leukemias are clonal hematopoietic malignant disease that arise from the malignant T r a n s f o r m a t i o n of an early Hematopoietic stem.
HAEMATOLOGY PRESENTATION TZE YENG YEOH MBChB II (2003)
Haematological Malignancy leukaemia and lymphoma,myeloma Concepts and principles Medical Students 2010.
Myeloprolifrative disorders -Chronic Myelogenouse Leukemia - Primary Poly Cythemia ( vira ) - Essential Thrombocythemia - Myelofibrose Myeloid Methaplasia.
C HRONIC LEUKEMIAS. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
CML.  Stem cell disorder  Characterized by myeloproliferation  Well-described clinical course 9 9q+ 22 Ph 22q- BCR ABL BCR ABL Translocation Transcription.
INVESTIGATION OF LEUKOCYTES. CHANGES IN LETSKOTYC FORMULAS IN VARIOUS PATHOLOGICAL CONDITIONS. CLINICAL AND LABORATORY DIAGNOSIS OF HEMOBLASTOSIS.
Malignancies of lymphoid cells ↑ incidence in general …. CLL is the most common form leukemia in US: Incidence in 2007: 15,340 Origin of Hodgkin lymphoma.
Leukaemias and lymphomas. Etiology, pathogenesis. Diagnostics
Chronic lymphocytic leukemia What is C.L.L. ? a chronic disease one particular type of lymphocyte (B-cells) accumulates. not rapidly growing and proliferating.
Chronic myeloid leukaemia Cancer of granulocyte production Too many (non functioning) granulocytes are produced Bone marrow is overcrowded with ineffective.
Myelofibrosis Chronic idiopathic myelofibrosis Progressive fibrosis of the marrow & increase connective tissue element Agnogenic myeloid metaplasia  Extramedullary.
Hematology and Hematologic Malignancies
Chronic leukemia 1. Chronic Lymphocytic leukemia (CLL) * Definition: Chronic neoplastic disorder characterized by accumulation of small mature-looking.
Dr Nauman Butt – Royal Liverpool University Hospital CML Patient Seminar - 14 th November 2015 What is CML? How do we treat it? Get up to speed…
Chronic myeloid leukaemia( CML);. CML is an excessive proliferation with fairly normal maturation. The disease occurs mainly between 30 and 80 years with.
CHRONIC LEUKEMIA Dr. Hayam Hebah Associate professor of Internal Medicine AL Maarefa College.
Heterogeneous group of hematopoietic neoplasms Uncontrolled proliferation and decreased apoptotic activity with variable degrees of differentiation Composed.
Acute Lymphocytic Leukaemia. A disease of the young – unless a “transformed” leukaemia Acute Lymphocytic Leukaemia.
..  Neoplastic proliferation of small mature appearing  lymphocytes and account 25% of leukemia  It is rare before 40 years of age, the median age.
White blood cells and their disorders Dr K Hampton Haematologist Royal Hallamshire Hospital.
Hematopoetic Cancers. Hematopoesis Leukemia New diagnoses each year in the US: 40, 800 Adults 3,500 Children 21,840 died of leukemia in 2010.
Myeloproliferative disorder Clonal evolution Clonal evolution & stepwise progression to fibrosis, marrow failure or acute blast phase.
Haematology Aaqid Akram MBChB (2013) Clinical Education Fellow.
Chronic Myeloid Leukemia
Case report Sudden blastic transformation in patient with chronic myeloid leukemia treated with imatinib mesylate Mehrdad Payandeh,MD Hematology, Medical.
Chronic leukemias أ. م. د. محمد شنين علي العبادي معاون عميد كلية الطب / جامعة كربلاء ورئيس فرع الامراض والطب العدلي M. B. Ch. B. & F. I. C. P.(Hematopathology)
LEUKEMIA Dr. Omar Alshaer. Acute Leukemia.
Acute lymphoblastic leukemia in children
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives chronic myeloid leukaemia (CML) Haematopoietic malignancies Polycythemia vera (PV) Idiopathic myelofibrosis.
The Chronic Lymphoid Leukaemias
Chronic myeloid leukaemia
Associate professor of Internal Medicine
PRIMARY THROMBOCYTHEMIA;-
Myeloproliferative disorder Clonal evolution Clonal evolution & stepwise progression to fibrosis, marrow failure or acute blast phase.
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
CHRONIC LEUKAEMIA Mousa Q.Hussein Assistant Professor
11 th lecture Chronic myeloid leukaemia By DR Fatehia Awny Faculty of Health Science Beirut Arab University
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
CHRONIC MYELOID LEUKEMIA (CML)
Chronic leukemias CML CLL MDS.
Associate professor of Internal Medicine
Case Study ….
Chronic Leukemia Kristine Krafts, M.D..
CASE STUDY Leukemia.
Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin)
Case study A 36-year-old woman presented with a two-month history of increasing fatigue and abdominal fullness with accompanying loss of appetite. There.
Chronic Leukemia Dr. Noha Noufal.
CHRONIC LEUKEMIA BY: DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST
Presentation transcript:

Chronic myeloid leukaemia (CML) CML is characterized by an uncontrolled clonal proliferation of myeloid cells. It accounts for 15% of leukaemias. It is a myeloproliferative disorder having features in common with these diseases eg splenomegaly. It occurs most often between 40-60yrs, with a slight male predominance, and is rare in childhood

Philadelphia chromosome (Ph) Present in >80% of those with CML. It is a hybrid chromosome comprising reciprocal translocation between the long arm of chromosome 9 and the long arm of chromosome 22 t(9;22) . Those without Ph have a worse prognosis.

Symptoms Mostly chronic and insidious: weight decreases, tiredness, fever, sweats. There may be features of gout (due to purine breakdown), bleeding (platelet dysfunction), and abdominal discomfort (splenic enlargement). ~30% are detected by chance. Signs Splenomegaly (>75%) often massive. Hepatomegaly, anaemia, bruising

Investigation WBC increases(often upto 500,000/mm cu) with whole spectrum of myeloid cells ie increase in myelocytes, neutrophils, basophils, eosinophils. Hb decrease or normal, platelets variable. Urate increase, B12 increase. Neutrophil alk phos score decrease. Bone marrow is hypercellular. Ph found on cytogenetic analysis of blood or bone marrow.

Treatment of CML Chemotherapy Imatinib, has revolutionized CML therapy. It is more effective than the previous gold standard of – interferon, cytarabine in chronic phase patients, in terms of preventing disease progression. The drug may also be effective in accelerated phase and blast crises. Imatinib gives high haematological response rates (>90) SE: usually mild: nausea, cramps, oedema, skin rash, headache, arthralgia. May cause myelosuppression

Hydroxyurea may still be used in patients intolerant of imatinib Busulfan is very rarely used now. The use of interferon in CML has declined dramatically with the introduction of imatinib, but -interferon may still have a role in combination therapy. Treatment of myeloblastic transformation with chemotherapy rarely achieves lasting remission and allogeneic transplantation offers the only hope of long-term survival

Stem cell transplantation Allogeneic transplantation from a HLA matched sibling or unrelated donor is the only curative treatment but carries significant morbidity and mortality.

Chronic lymphocytic leukaemia (CLL) This is a monoclonal proliferation of non-functional mature B lymphocytes (T cell CLL occurs rarely). CLL constitutes 25% of all leukaemias. Male:female=2:1. It is a disease of the elderly, median age at diagnosis is ~65 years.

Staging correlates with survival: Stage 0 Lymphocytosis alone. Median Survival >13yrs I Lymphocytosis + lymphadenopathy. 8yrs II Lymphocytosis + spleno- or hepatomegaly. 5yrs III Lymphocytosis + anaemia (Hb <11g/dL). 2yrs IV Lymphocytosis + platelets < 1yr

Symptoms (none in 25%) Infection, anaemia, bleeding. If severe: weight decreases, sweats, anorexia. Signs Enlarged, rubbery, non-tender nodes. Splenomegaly, hepatomegaly.

Investigation Increase lymphocytes may be marked 95 % of WBC. Later: autoimmune haemolysis , Marrow infiltration: decrease Hb, decrease neutrophils, decrease platelets. Complications 1 Autoimmune haemolysis. 2 Increase Infection due to hypogammaglobulinaemia (=decrease IgG), bacterial, viral especially herpes zoster. 3 Marrow failure

Death is often due to infection (commonly pneumococcus, haemophilus, meningococcus, Candida or aspergillosis), or transformation to aggressive lymphoma .

Treatment If asymptomatic, the patient can be monitored. Chlorambucil is used to decrease lymphocyte count, improve marrow function, and reduce node size. Dose: eg 0.1- 0.2mg/kg daily PO. Steroids are used in autoimmune haemolysis. Radiotherapy: For relief of lymphadenopathy or splenomegaly. Supportive care: Transfusions, IV human immunoglobulin if recurrent infections. Bone marrow transplant is currently experimental.

Prognosis Current treatments are mainly non-curative at present. Prognosis is often good: depends on stage and molecular/immunological factors.

Difference between CML and CLL Anemia Early presentation Late presentation Sternal tenderness Present Absent Lymphadenopathy May present in terminal stage Present from early stage Splenomegaly Huge Moderate Bleeding episodes May occur in terminal stage May occur from early stage WBC 100000 to 500000/mm cu., mainly myelocyte 10000 to 50000/mm cu. ,mainly lymphocytes